Bukavina L, Bensalah K, Bray F, et al. Epidemiology of renal cell carcinoma: 2022 update. Eur Urol. 2022;82:529–42. https://doi.org/10.1016/j.eururo.2022.08.019.

Article  PubMed  Google Scholar 

Du Z, Chen W, Xia Q, et al. Trends and projections of kidney cancer incidence at the global and national levels, 1990–2030: a Bayesian age-period-cohort modeling study. Biomark Res. 2020;8:16. https://doi.org/10.1186/s40364-020-00195-3.

Article  PubMed  PubMed Central  Google Scholar 

Lavallée LT, Tanguay S, Jewett MA, et al. Surgical management of stage T1 renal tumors in Canadian academic centers. Can Urol Assoc J. 2015;9:99. https://doi.org/10.5489/cuaj.2598.

Article  PubMed  PubMed Central  Google Scholar 

Sun M, Bianchi M, Trinh Q-D, et al. Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities. BJU Int. 2013;111:67–73. https://doi.org/10.1111/j.1464-410X.2012.11254.x.

Article  PubMed  Google Scholar 

Yanagisawa T, Mori K, Kawada T, et al. Differential efficacy of ablation therapy versus partial nephrectomy between clinical T1a and T1b renal tumors: a systematic review and meta-analysis. Urol Oncol Semin Orig Invest. 2022;40:315–30. https://doi.org/10.1016/j.urolonc.2022.04.002.

Article  Google Scholar 

NCCN Guidelines Version 1.2024 Kidney Cancer, Robert Mozer et al.

Campbell SC, Clark PE, Chang SS, et al. Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part I. J Urol. 2021;206:199–208. https://doi.org/10.1097/JU.0000000000001911.

Article  PubMed  Google Scholar 

Finelli A, Ismaila N, Bro B, et al. Management of small renal masses: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2017;35:668–80. https://doi.org/10.1200/JCO.2016.69.9645.

Article  PubMed  Google Scholar 

Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol. 2009;182:844–53. https://doi.org/10.1016/j.juro.2009.05.035.

Article  PubMed  Google Scholar 

Puijk RS, Ahmed M, Adam A, et al. Consensus guidelines for the definition of time-to-event end points in image-guided tumor ablation: results of the SIO and DATECAN initiative. Radiology. 2021;301:533–40. https://doi.org/10.1148/radiol.2021203715.

Article  PubMed  Google Scholar 

Filippiadis DK, Binkert C, Pellerin O, et al. Cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Intervent Radiol. 2017;40:1141–6. https://doi.org/10.1007/s00270-017-1703-4.

Article  CAS  PubMed  Google Scholar 

Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications. Ann Surg. 2009;250:187–96. https://doi.org/10.1097/SLA.0b013e3181b13ca2.

Article  PubMed  Google Scholar 

Yao XI, Wang X, Speicher PJ, et al. Reporting and guidelines in propensity score analysis: a systematic review of cancer and cancer surgical studies. JNCI J Natl Cancer Inst. 2017. https://doi.org/10.1093/jnci/djw323.

Article  PubMed  Google Scholar 

Zhao Q-Y, Luo J-C, Su Y, et al. Propensity score matching with R: conventional methods and new features. Ann Transl Med. 2021;9:812–812.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rubin DB. Using propensity scores to help design observational studies: application to the tobacco litigation. Health Serv Outcomes Res Methodol. 2001;2:169–88. https://doi.org/10.1023/A:1020363010465.

Article  Google Scholar 

Weight CJ, Lieser G, Larson BT, et al. Partial nephrectomy is associated with improved overall survival compared to radical nephrectomy in patients with unanticipated benign renal tumours. Eur Urol. 2010;58:293–8. https://doi.org/10.1016/j.eururo.2010.04.033.

Article  PubMed  Google Scholar 

Weight CJ, Larson BT, Gao T, et al. Elective partial nephrectomy in patients with clinical T1b renal tumors is associated with improved overall survival. Urology. 2010;76:631–7. https://doi.org/10.1016/j.urology.2009.11.087.

Article  PubMed  Google Scholar 

Li L, Zhu J, Shao H, et al. Long-term outcomes of radiofrequency ablation vs. partial nephrectomy for cT1 renal cancer: a meta-analysis and systematic review. Front Surg. 2023. https://doi.org/10.3389/fsurg.2022.1012897.

Article  PubMed  PubMed Central  Google Scholar 

Morkos J, Porosnicu Rodriguez KA, Zhou A, et al. Percutaneous cryoablation for stage 1 renal cell carcinoma: outcomes from a 10-year prospective study and comparison with matched cohorts from the national cancer database. Radiology. 2020;296:452–9. https://doi.org/10.1148/radiol.2020192325.

Article  PubMed  Google Scholar 

Filippiadis D, Mauri G, Marra P, et al. Percutaneous ablation techniques for renal cell carcinoma: current status and future trends. Int J Hyperth. 2019;36:21–30. https://doi.org/10.1080/02656736.2019.1647352.

Article  CAS  Google Scholar 

Efthymiou E, Siatelis A, Liakouras C, et al. Computed tomography-guided percutaneous microwave ablation for renal cell carcinoma: impact of tumor size on the progression survival rates. Diagnostics. 2021;11:1618. https://doi.org/10.3390/diagnostics11091618.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lucignani G, Rizzo M, Ierardi AM, et al. Percutaneous microwave ablation is comparable to cryoablation for the treatment of T1a renal masses: results from a cross-sectional study. Clin Genitourin Cancer. 2022;20:e506–11. https://doi.org/10.1016/j.clgc.2022.07.004.

Article  PubMed  Google Scholar 

Castellana R, Natrella M, Fanelli G, et al. Efficacy and safety of MWA versus RFA and CA for renal tumors: a systematic review and meta-analysis of comparison studies. Eur J Radiol. 2023;165:110943. https://doi.org/10.1016/j.ejrad.2023.110943.

Article  PubMed  Google Scholar 

Panhelleux M, Balssa L, David A, et al. Evaluation of local control after percutaneous microwave ablation versus partial nephrectomy: a propensity score matched study. Prog Urol. 2023. https://doi.org/10.1016/j.purol.2023.09.021.

Article  Google Scholar 

Efthymiou E, Velonakis G, Charalampopoulos G, et al. Computed tomography-guided percutaneous microwave ablation for renal cell carcinoma: evaluating the performance of nephrometry scores. Eur Radiol. 2023. https://doi.org/10.1007/s00330-023-09774-y.

Article  PubMed  Google Scholar 

Cazalas G, Klein C, Piana G, et al. A multicenter comparative matched-pair analysis of percutaneous tumor ablation and robotic-assisted partial nephrectomy of T1b renal cell carcinoma (AblatT1b study—UroCCR 80). Eur Radiol. 2023;33:6513–21. https://doi.org/10.1007/s00330-023-09564-6.

Article  PubMed  Google Scholar 

Shapiro DD, Wells SA, Best SL, et al. Comparing outcomes for patients with clinical T1b renal cell carcinoma treated with either percutaneous microwave ablation or surgery. Urology. 2020;135:88–94. https://doi.org/10.1016/j.urology.2019.09.024.

Article  PubMed  Google Scholar 

Yeaman C, Marchant R, Lobo JM, et al. Cost-effectiveness analysis: percutaneous microwave ablation vs robotic-assisted partial nephrectomy for small renal masses. Abdom Radiol. 2022;48:411–7. https://doi.org/10.1007/s00261-022-03692-1.

Article  Google Scholar 

Junker T, Duus L, Rasmussen BSB, et al. Quality of life and complications after nephron-sparing treatment of renal cell carcinoma stage T1—a systematic review. Syst Rev. 2022;11:4. https://doi.org/10.1186/s13643-021-01868-2.

Article  PubMed  PubMed Central  Google Scholar